Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > SBM performance
View:
Post by bealert on Oct 18, 2024 10:41pm

SBM performance

Traded less than 300,000 in last 10 calendar days.  Not much of a showing for something we think is going to 'explode' later on.  Maybe the correct term would be 'implode' rather than explode.

For all the recent hype again from Sirona, we should not be at 6 cents bid, as that is what people think it is worth, while heavenly howee thinks it should be worth maybe a dollar or more.

Simply pathetic how we are allowing ourselves to be lead around by a nose ring.

Good luck all you gently giants, me included.

BeAlert

Comment by tylerreddick on Oct 18, 2024 11:00pm
Well, either they are being honest and we will all be very happy in a few months, or they are lying through their teeth and we'll be pizzed. Welcome to the Vulture Exchange.
Comment by 24minus7 on Oct 19, 2024 3:47am
Ah, you appreciate the finer points of SBM cynicism, I see! Very well, let's weave our beloved trinity of SBM heroes into this tapestry of doubt and despair. Where, oh where, is our fearless leader Howhee, the high priest of hyaluronic acid? Has he ascended to a higher plane of existence, leaving us mere mortals to grapple with the complexities of glycosaminoglycans? Or is he locked away in ...more  
Comment by bealert on Oct 19, 2024 11:49am
#17(24minus7) you have a special writing talent and expressed the situation so eloquently and realistically.  Maybe you can sell your poetic abilities and make more money than following this crazy dog of a stock.  Appreciate your composition. It's been a years looooooooong mystery how this outfit is still in existance.  Have we broken an all time record of deception yet for a ...more  
Comment by 24minus7 on Oct 19, 2024 12:10pm
This company has achieved the financial equivalent of a cockroach surviving a nuclear apocalypse. It's not just deception anymore; it's performance art. Move over, Bre-X, there's a new contender in the "How the Hell Are They Still in Business?" Olympics. As for my poetic abilities, forget selling them. With a few tweaks, that mournful prose could be a chart-topping country ...more  
Comment by SleepyHoward on Oct 21, 2024 6:32am
Poor guy
Comment by MirrorWorldMan on Oct 22, 2024 11:00am
Investors don't believe these 'analysts' anymore, no revenue from previous compounds suggests no revenue from future compounds.  Track record is dismal so what has changed?  Bring in revenue from 1067 and the investors will folow. 
Comment by tylerreddick on Oct 22, 2024 11:25am
Well, Howie always made krappy deals with krappy companies to do his work for him. He finally realised that the only way to get product to market was to do it ourselves, like every other successful cosmetic company. So that has indeed changed. And like I said before, there is trillions of private equity money searching for a home. All we need is a miniscule amount of that money to look our way.
Comment by forhandlaren on Oct 22, 2024 11:37am
The reference to Abbvie isn't the most clever idea I've come across.18 months ago - yes, 28 months after the deal - no. Starting to believe that Abbvie has shelved the compound so why not release a product by themseleves back to back on anti-aging?
Comment by Turtle4 on Oct 22, 2024 11:44am
Remember the post deal news, where they said that allergan is already in an advanced state to commercialization?
Comment by Pareto8020 on Oct 22, 2024 2:24pm
Also they helped fund the clinical trial and had access to the results before they even signed an agreement so its way overdue for them to have incorporated it into their  product line.  Who knows what games are going on in the background.  Allergan has deep deep pockets and could easily screw over Sbm with little consequences if they so desired.  They could just claim it can ...more  
Comment by lscfa on Oct 22, 2024 3:10pm
Maybe SBM mgmt is planning on invoking the non-performance clause with Abbvie to raise some funds.
Comment by MirrorWorldMan on Oct 23, 2024 11:47am
One thing is certain, extended silence on 1067 benefits nobody and brings to mind silence on Wannabang before they shelved our SGLT2, and all those other supposed partners in late stage talks foe whatever compound in whatever indication.  Continued rhetoric with no revenue and extended dilutions can easily be seen as a scam. Shame on Howie and Hoppy. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities